Sensex Falls 220 Points, Nifty Nears 24,900 as Pharma Stocks Hit Record High

 

The Indian stock market traded lower on Monday, with the Sensex falling more than 220 points and the Nifty 50 hovering around the 24,900 mark. However, weakness in the broader market did not extend to every sector. Pharmaceutical and healthcare stocks attracted strong buying interest, pushing the Nifty Pharma index to a fresh record high.

At around 1:00 PM, the Sensex was trading at 80,778.44, down 220.96 points or 0.27 per cent. The Nifty 50 stood at 24,920, declining 65.20 points or 0.26 per cent.

Healthcare and pharmaceutical companies remained among the strongest performers during the session.

Key developments from Monday's trading session:

  • Nifty Pharma hits record: The index climbed 2.8 per cent to a new high of 29,224.85, supported by strong gains in pharmaceutical companies.

  • Healthcare stocks outperform: Gland Pharma, Divi's Laboratories and Glenmark Pharmaceuticals emerged among the leading gainers in the Nifty Healthcare index.

  • Sai Life Sciences jumps 9%: Shares touched an intraday high of ₹1,897.30 after the company reported a 17 per cent year-on-year increase in consolidated net profit to ₹98 crore for the September quarter of FY27.

  • L&T secures metro order: Larsen & Toubro received a significant order worth between ₹1,200 crore and ₹2,500 crore from Noida Metro Rail Corporation for the Aqua Line Extension Project.

  • Banking shares advance: SBI, Bank of India, Indian Bank, Canara Bank and other banking stocks gained up to 3 per cent, with the Nifty Bank outperforming several sectoral indices.







  • Blue Dart declines: Shares dropped 4 per cent to ₹4,394.20 following muted EBITDA margin growth in the company's September quarter results.

  • Gold and silver extend gains: International gold prices crossed $4,100 per ounce as softer crude oil prices eased inflation concerns. Expectations of tight US Federal Reserve monetary policy continued to limit gains.

Earlier in the session, the market decline was relatively limited. At noon, the Sensex was down 58.50 points at 80,940.90, while the Nifty slipped 18.55 points to 24,967.85. Selling pressure increased as trading progressed.

The pharmaceutical sector's strong performance stood out against the broader market weakness. Divi's Laboratories and Laurus Labs helped drive the Nifty Pharma index higher, while buying in healthcare companies reflected continued investor interest in the sector.

The session highlighted a divided market trend. While benchmark indices struggled to maintain momentum, pharmaceutical and selected banking stocks continued to attract buyers. Investors will now watch upcoming corporate earnings, global market signals, crude oil prices and US monetary policy developments for further direction.

Post a Comment

0 Comments